INTRODUCTION AND OBJECTIVES: Recent evidence suggested the importance of preoperative patients' quality of life on postoperative functional and oncological outcomes. The aim of our study was to evaluate the impact of preoperative quality of life on post radical prostatectomy overall survival.
METHODS: Between 2012 and 2017, all patients undergoing robotic radical prostatectomy (RRP) for prostate cancer were enrolled. Demographic, clinical and histological characteristics of the patients were recorded. Preoperative quality of life was evaluated with the EORTC QLQ-C30 including the Global Health score (GHS). Cox regression was used to evaluate the role of GHS as a predictor of patients' overall survival. RESULTS: Overall 7,606 patients were enrolled. Median age was 65 (IQR: 60/70) years, median BMI was 26.6 (IQR:25/29) kg/m2, median PSA was 7 (IQR:6/11) ng/ml and median prostate volume was 37 (IQR:28/52) ml. Overall 1,911/7,606 patients presented high grade disease on prostate biopsy and 1,521/7,606 (20%) presented advanced clinical stage. 193 patients died (2.5%) during a median follow-up of 36 months (IQR: 12/60). On multivariate analysis age, biopsy prognostic grade group (PGG), ASA score and EORTC-Global Health Score were the only preoperative predictors of overall survival.
CONCLUSIONS: In our study a comprehensive evaluation of pre-operative patients' quality of life, assessed by the EORTC QLQ-C30 questionnaire, and comorbidities can predict the long-term survival in patients treated with robotic radical prostatectomy. Although further studies should confirm our results, we firstly showed the importance to assess patients 'quality of life before radical prostate surgery. EBRT and brachytherapy (n[14) , HIFU (n[9), cryoablation (n[18), and other (electroporation, microwave, n[4) therapies. We analyzed the differences in clinical and oncological outcomes between RAD and ABL groups by using t-test, chi-square and Fisher's exact tests.
RESULTS: Preoperative characteristics were similar between 2 groups, except for sexual function (Table 1) . Before surgery, 38% of patients in ABL group were potent as compared to 18% in RAD group (p[0.06). Operative times, perioperative complication rates, postoperative catheter duration and cystographic leak rates were not significantly different between 2 groups (Table 1) . At final pathology, ABL group showed higher non-organ confined disease rates (71% vs 47.8%, p[0.036) and higher positive surgical margin (PSM) rates as compared to RAD group (45% vs. 17%, p[0.004) .
Based on functional outcomes follow-up data (n[105), 9.7% of men in RAD and 26% of men in ABL group achieved potency (p[0.125) at a median 24.2 months follow-up (range: 3-116). Postoperative full continence (no pads/day) and social continence (0-1 pad/ day) rates were significantly higher in ABL as compared to RAD group (73.9% vs. 46.3%, p[0.031 and 88.9% vs. 54.7%, p[0.012, respectively) . Full continence rates at 3, 6, 9, and 12 months were significantly higher in ABL group (Table 1) .
CONCLUSIONS: All salvage prostatectomies are not the same. When discussing sRALP, patients should be warned that RAD is associated with higher postoperative incontinence rates and ABL is associated with higher non-organ confined disease and PSM rates. Vol. 201, No. 4S, Supplement, Sunday, May 5, 2019 THE JOURNAL OF UROLOGY Ò e875
Copyright © 2019 American Urological Association Education and Research, Inc. Unauthorized reproduction of this article is prohibited.
